MFDS Immediately Implements Rapid Regulatory Support Guidelines for Stable Supply of Goods
South Korea’s MFDS introduces rapid regulatory support measures, including expedited approvals and temporary packaging flexibility, to ensure stable supply amid global disruptions.
MFDS | Pharmaceuticals | Regulatory AffairsMFDS Establishes Expedited Review Regulations for Biosimilars in South Korea
South Korea’s MFDS introduces expedited review regulations for biosimilars, reducing approval timelines and enhancing flexibility in managing manufacturing changes to support the biopharmaceutical sector.
MFDS | Pharmaceuticals | Regulatory AffairsSouth Africa: Clinical Trial Liability Insurance Guideline
Strengthening Risk Coverage & Participant Protection
Effective from March 27, 2026SAHPRA | Pharmaceuticals | Regulatory AffairsChina: Registration Service Platform Launch
Advancing Digital Drug Registration & Public Access
Effective from March 30, 2026NMPA | Pharmaceuticals | Regulatory AffairsChina: Conditional Drug Approval System Update
Accelerating Access for Critically Ill Patients
Effective from March 30, 2026NMPA | Pharmaceuticals | Regulatory Affairs
Consult
